Metabolic perturbation of an Hsp90 C-domain inhibitor in a lung cancer cell line, A549 studied by NMR-based chemometric analysis
- Authors
- 허수정; 박성진; 이혜원; 신애향
- Issue Date
- 2014
- Publisher
- 한국자기공명학회
- Keywords
- Hsp90; C-domain inhibitor; biomarker; metabolomics
- Citation
- Journal of the Korean Magnetic Resonance Society, v.18, no.1, pp.10 - 14
- Journal Title
- Journal of the Korean Magnetic Resonance Society
- Volume
- 18
- Number
- 1
- Start Page
- 10
- End Page
- 14
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/13672
- DOI
- 10.6564/JKMRS.2014.18.1.010
- ISSN
- 1226-6531
- Abstract
- Hsp90 is a good drug target molecule that is involved in regulating various signaling pathway in normal cell and the role of Hsp90 is highly emphasized especially in cancer cells. Thus, much efforts for discovery and development of Hsp90 inhibitor have been continued and a few Hsp90 inhibitors targeting the N-terminal ATP binding site are being tested in the clinical trials. There are no metabolic signature molecules that can be used to evaluate the effect of Hsp90 inhibition. We previously found a potential C-domain binder named PPC1 that is a synthetic small molecule. Here we report the metabolomics study to find signature metabolites upon treatment of PPC1 compound in lung cancer cell line, A549 and discuss the potentiality of metabolomic approach for evaluation of hit compounds.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 약학대학 > 약학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.